Literature DB >> 32316719

[A special on epidemic prevention and control: analysis on expression of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues].

B N Zhang1, Q Wang1, T Liu1, S Q Dou1, X Qi1, H Jiang1, B X Qi1, B Zhang1, Q J Zhou1.   

Abstract

This article was published ahead of print on the official website of Chinese Journal of Ophthalmolog on Apirl 22,2020. Objective: Angiotensin converting enzyme 2 (ACE2) and Transmembrane serine protease 2 (TMPRSS2) are the key proteins for 2019-nCoV entry into host cells. To evaluate the potential infection risk of 2019-nCoV on ocular surface, we compared ACE2 and TMPRSS2 expression among different eye tissues.
Methods: Experimental study. Thirty mice were assigned to male, female, aged, diabetic and non-diabetic groups, with 6 mice in each group. Real-time PCR was performed to quantify ACE2 and TMPRSS2 gene expression in conjunctiva, cornea, lacrimal gland, iris, lens, retina, lung, heart, kidney, and liver from male mice. Immunohistochemistry staining was applied to visualize the distribution of the two proteins in different mice tissues, and in human corneal and conjunctival sections. Published transcriptome datasets were extracted to generate the expression comparasion of ACE2 and TMPRSS2 between human conjunctival and corneal tissues, and results were analyzed using Mann-Whitney U test. Female mice, aged mice, STZ-induced diabetic mice, diabetic group control mice were also subjected to ACE2 expression analysis. Results were analyzed using Student's t-test.
Results: The expression of ACE2 and TMPRSS2 genes were the highest in conjunctiva among all the six mice eye tissues explored. The expression of these two genes in conjunctiva were lower than that in kidney and lung. ACE2 and TMPRSS2 shared similar expression pattern with the staining concentrated in corneal epithelium, conjunctival epithelium and lacrimal gland serous cells. The expression levels of ACE2 showed gender difference. Female mice had lower ACE2 in conjunctiva and cornea than male mice, with the expression levels being only 43% (t=3.269, P=0.031) and 63% (t=4.080, P=0.015) of that in the male conjunctiva and cornea, respectively. Diabetic mice expressed more ACE2 in conjunctiva (1.21-fold, P>0.05) and lacrimal gland (1.10-fold, P>0.05) compared with the control group. No significant difference on ACE2 expression was found between the aged and young adult mice. The expression level of human conjunctiva ACE2 and TMPRSS2 were significantly higher than that in the cornea (P=0.007), with 5.74-fold and 12.84-fold higher in the conjunctiva than in the corneal epithelium cells, which resembled the situation in mice.
Conclusion: The observation of high-level ACE2 and TMPRSS2 expression in conjunctiva among the 6 eye tissues examined suggests that conjunctiva serves as an infection target tissue of 2019-nCoV. (Chin J Ophthalmol, 2020, 56:438-446).

Entities:  

Keywords:  2019-nCoV; Conjunctiva; Diabetes complications; Epithelium, corneal; Peptidyl-dipeptidase A; Serine endopeptidases

Mesh:

Substances:

Year:  2020        PMID: 32316719     DOI: 10.3760/cma.j.cn112142-20200310-00170

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  15 in total

1.  Detection of coronavirus in tear samples of hospitalized patients with COVID-19.

Authors:  Mine Ozturk; Deniz Kumova; Sema Alacam; Hatice Erdogan; Feyza Onder
Journal:  Int Ophthalmol       Date:  2022-07-20       Impact factor: 2.029

2.  Impact of the COVID-19 Pandemic on Keratoplasty and Corneal Eye Banking.

Authors:  Dena Ballouz; Onkar B Sawant; Susan Hurlbert; Michael S Titus; Parag A Majmudar; Ashok Kumar; Yunshu Zhou; David C Musch; Shahzad I Mian
Journal:  Cornea       Date:  2021-08-01       Impact factor: 3.152

Review 3.  [Ophthalmological care of SARS-CoV-2 positive patients in intensive care units].

Authors:  Luisa Schwarz; Christoph Lwowski; Ingo Schmack; Michael Müller; Elisabeth Adam; Kai Zacharowski; Thomas Kohnen
Journal:  Ophthalmologe       Date:  2020-07       Impact factor: 1.059

Review 4.  [Can SARS-CoV-2 infect the eye?-An overview of the receptor status in ocular tissue].

Authors:  Sven Schnichels; Jens Martin Rohrbach; Tarek Bayyoud; Sebastian Thaler; Focke Ziemssen; José Hurst
Journal:  Ophthalmologe       Date:  2020-07       Impact factor: 1.059

Review 5.  Ocular Involvement in Coronavirus Disease 2019: Up-to-Date Information on Its Manifestation, Testing, Transmission, and Prevention.

Authors:  Ziyan Chen; Gang Yuan; Fang Duan; Kaili Wu
Journal:  Front Med (Lausanne)       Date:  2020-11-30

Review 6.  Potential of Ocular Transmission of SARS-CoV-2: A Review.

Authors:  Brad P Barnett; Karl Wahlin; Michal Krawczyk; Doran Spencer; Derek Welsbie; Natalie Afshari; Daniel Chao
Journal:  Vision (Basel)       Date:  2020-09-01

Review 7.  Human coronaviruses: ophthalmic manifestations.

Authors:  Mohd-Asyraaf Abdul-Kadir; Lik Thai Lim
Journal:  BMJ Open Ophthalmol       Date:  2020-11-02

8.  Acute Corneal Endothelial Graft Rejection With Coinciding COVID-19 Infection.

Authors:  Sierra X Jin; Viral V Juthani
Journal:  Cornea       Date:  2021-01       Impact factor: 3.152

Review 9.  [Ocular post-mortem findings in patients having died from COVID-19].

Authors:  Karin U Löffler; Aja Reinhold; Martina C Herwig-Carl; Alexandar Tzankov; Frank G Holz; Hendrik P N Scholl; Peter Meyer
Journal:  Ophthalmologe       Date:  2020-07       Impact factor: 1.059

10.  Expression of the COVID-19 receptor ACE2 in the human conjunctiva.

Authors:  Clemens Lange; Julian Wolf; Claudia Auw-Haedrich; Anja Schlecht; Stefaniya Boneva; Thabo Lapp; Ralf Horres; Hansjürgen Agostini; Gottfried Martin; Thomas Reinhard; Günther Schlunck
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.